In a joint effort with the Pharmaceutical Research and Manufacturers of America (PhRMA), NOF released a report on new, innovative therapies being developed for the treatment of osteoporosis. The report, Medicines in Development for Osteoporosis, examines the nationwide effects of the disease and explores how new medications can improve and save lives.
Links to the press release announcing the report, a link to the full report and list of medicines in development are included below.
Medicines in Development For Osteoporosis